About Pre-clinical Imaging
Pre-clinical Imaging is in vivo imaging of small animals, which had been progressively deployed in drug development process. It helps in the visualizing and monitoring of animals for research with respect to tissue, organ, cell (at molecular level), and physiological and environmental changes. One of the main application areas of pre-clinical imaging is early detection of diseases. Currently the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET+CT and SPECT+CT are the most used imaging combinations. In vivo imaging is increasingly used in target identification, compound optimisation and pre-Phase I studies, and in the drug development process. Thus, it bridges the gap between in vitro exploratory and in vivo clinical research.
TechNavio's analysts forecast the Global Pre-clinical Imaging market to grow at a CAGR of 15.02 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and growth prospects of the Global Pre-clinical Imaging market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of pre-clinical imaging systems. Pre-clinical imaging systems can be segmented based on the type of equipment, as mentioned below:
• Micro MRI
• Micro-PET
• Micro-CT
• PAT
• SPECT
• Multi-modality
• Optical Imaging
• Ultrasound
The report presents the vendor landscape and a corresponding detailed analysis of the top seven vendors in the Global Pre-clinical Imaging market. The vendor landscape in this report focuses on the vendors that provide access to new and technologically advanced pre-clinical imaging systems. The report also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.
TechNavio's report, Global Pre-clinical Imaging Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Pre-clinical Imaging market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Aspect Imaging
• Bioscan (Subsidiary of Trifoil Imaging)
• Bruker Corporation
• Mediso Medical Imaging Systems
• PerkinElmer
• Siemens Healthcare
• Thermo Fisher Scientific
Other Prominent Vendor
• Agilent Technologies
• Capintec
• Hitachi Medical
• LI-COR Biosciences
• Miltenyi Biotec GMBH
• Naviscan
• Positron
• Promega
• Quintiles
Market Driver
• Increased R&D activities in Pharma Companies
• For a full, detailed list, view our report
Market Challenge
• High Cost
• For a full, detailed list, view our report
Market Trend
• Use of Multi-modalities Imaging Systems
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview.
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Type of Modality
08. Global Single Modality Imaging Technique Market
08.1 Market Overview
08.1.1 Market Size and Forecast
09. Global Multi-modality Imaging Technique Market
09.1 Market Overview
09.1.1 Market Size and Forecast
10. Market Segmentation by Sub-classification
10.1.1 In vivo Pre-Clinical Imaging Reagents
10.1.2 Diseases and Therapeutics areas targeted with Pre-Clinical Imaging
11. Geographical Segmentation
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors
19.3.1 Product Portfolio Matrix (Optional)
20. Key Vendor Analysis
20.1 Aspect Imaging
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Revenue by Business Segmentation
20.1.6 Revenue Comparison 2011 and 2012
20.1.7 Revenue by Geographical Segmentation
20.1.8 Key Information
20.1.9 SWOT Analysis
20.2 Trifoil Imaging Inc.
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Business Segmentation
20.2.4 Business Segmentation by Revenue 2012 and 2013
20.2.5 Geographical Segmentation by Revenue 2013
20.2.6 Business Strategy
20.2.7 Key Information
20.2.8 SWOT Analysis
20.3 Bruker Corporation
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation
20.3.4 Business Strategy
20.3.5 Key Developments
20.3.6 SWOT Analysis
20.4 Thermo Fisher Scientific Inc
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation
20.4.4 Revenue by Business Segmentation
20.4.5 Revenue Comparison by Business Segmentation 2012 and 2013
20.4.6 Revenue by Geographical Segmentation
20.4.7 Business Strategy
20.4.8 Key Developments
20.4.9 SWOT Analysis
20.5 Mediso Medical Imaging
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Product Segmentation
20.5.4 Recent Developments
20.5.5 SWOT Analysis
20.6 PerkinElmer, Inc.
20.6.1 Key Facts
20.6.2 Business Overview
20.6.3 Revenue by Business Segmentation 2012
20.6.4 Sales by Geography
20.6.5 Business Strategy
20.6.6 Key Developments
20.6.7 SWOT Analysis
20.7 Siemens Healthcare
20.7.1 Key Facts
20.7.2 Business Overview
20.7.3 Business Segmentation by Revenue 2013
20.7.4 Geographical Segmentation by Revenue 2013
20.7.5 Business Strategy
20.7.6 Key Developments
20.7.7 SWOT Analysis
21. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Pre-clinical Outsourcing Market 2014-2019 (US$ million)
Exhibit 3: Global Pre-Clinical Imaging Market 2014-2019 (US$ billion)
Exhibit 4: Global Pre-Clinical Imaging Market Segmentation by Modality Imaging
Exhibit 5: Global Pre-Clinical Imaging Market Segmentation by Modality Imaging
Exhibit 6: Global Pre-Clinical Imaging Market Segmentation by Modality Imaging 2014-2019 (US$ million)
Exhibit 7: Global Pre-Clinical Imaging Market Segmentation by Modality Imaging 2014-2019
Exhibit 8: Global Single Modality Imaging Market 2014-2019 (US$ billion)
Exhibit 9: Most Used Single Imaging Modality 2014
Exhibit 10: Most Used Single Imaging Modality 2014 (US$ million)
Exhibit 11: Global Multi-modality Imaging Market 2014-2019 (US$ billion)
Exhibit 12: Multi-modality Imaging Combinations 2014
Exhibit 13: Multi-modality Imaging Combinations 2014 (US$ million)
Exhibit 14: Global Pre-Clinical Imaging Market Segmentation by Technology
Exhibit 15: Key Diseases/Therapeutic areas Targeting with Pre-Clinical Imaging
Exhibit 16: Global Pre-Clinical Imaging Market Geography Segmentation 2014
Exhibit 17: Global Pre-Clinical Imaging Market Geography Segmentation 2014 (US$ million)
Exhibit 18: Drivers for Global Pre-Clinical Imaging Market
Exhibit 19: Challenges for Global Pre-Clinical Imaging Market
Exhibit 20: Trends for Global Pre-Clinical Imaging Market
Exhibit 21: Global Outsourcing Pre-Clinical Imaging Market
Exhibit 22: Global Outsourcing Pre-Clinical Imaging Market in 2014-2019 (US$ billions)
Exhibit 23: Aspect Imaging: Business Segmentation
Exhibit 24: Aspect Imaging: Revenue by Business Segmentation 2012
Exhibit 25: Aspect Imaging: Revenue by Business Segmentation 2011 and 2012 (US$ million)
Exhibit 26: Aspect Imaging: Revenue by Geographical Segmentation 2012
Exhibit 27: Trifoil Imaging Inc.: Business Segmentation 2013
Exhibit 28: Trifoil Imaging Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 29: Trifoil Imaging Inc.: Geographical Segmentation by Revenue 2013
Exhibit 30: Bruker Corporation: Business Segmentation 2013
Exhibit 31: Thermo Fisher Scientific Inc: Business Segmentation
Exhibit 32: Thermo Fisher Scientific Inc: Revenue by Business Segmentation 2013
Exhibit 33: Thermo Fisher Scientific Inc: Revenue Comparison by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 34: Thermo Fisher Scientific Inc: Revenue by Geographical Segmentation 2013
Exhibit 35: Mediso Medical Imaging: Product Segmentation 2013
Exhibit 36: PerkinElmer, Inc.: Revenue by Business Segmentation 2012
Exhibit 37: PerkinElmer, Inc.: Sales by Geography 2012
Exhibit 38: Siemens Healthcare: Business Segmentation by Revenue 2013
Exhibit 39: Siemens Healthcare: Geographical Segmentation by Revenue 2013
